Wafaa El-Sadr, MD, MPH, MPA is the founder and director of ICAP at Columbia University, University Professor of Epidemiology and Medicine, and Mathilde Krim-amfAR Professor of Global Health at Columbia University.
Through ICAP at Columbia University, the Center she founded and directs, she leads a team of 1800 individuals working in more than 30 countries, including in the US. ICAP designs and implements programs for research, education, training, and practice in more than 30 countries around the world. Her focus in on confronting major public health challenges including HIV, tuberculosis, malaria, maternal and child health, non-communicable diseases among others in partnership with in-country stakeholders.
Dr. El-Sadr is a principal investigator of the NIH-funded HIV Prevention Trials Network and has led other studies involving epidemiologic, behavioral, clinical, and implementation research. She has published more than 400 papers.
Dr. El-Sadr received her medical degree from Cairo University, a masters in public health (epidemiology) from Columbia’s Mailman School of Public Health, and a masters in public administration from Harvard University’s Kennedy School of Government. She was named as McArthur fellow in 2008, is a member of the National Academy of Medicine and a fellow of the African Academy of Sciences.
At the completion of this educational session, learners will:
- Be informed of the current epidemiological trends of COVID-19 in NYC and the US.
- Understand the successful aspects of the response and how key milestones were reached.
- Be able to describe the remaining challenges to responding to the pandemic in NYC and the US.
This CME activity has approved for AMA PRA Category 1 Credit™
for June 24, 2020 as a live activity. This activity will also be available as an enduring activity from June 25, 2020, through June 23, 2023.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Wafaa El-Sadr (Presenter) has no relevant financial relationships to disclose. Dr. El-Sadr will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation